The Fundamentals Report is an independent paid circulation newsletter and advertising report produced by NWBB Inc. . This paid advertising issue does not purport to provide an analysis of any company’s financial position or prospects and this is not to be construed as a recommendation by The Fundamentals Report and is not in any way to be construed as an offer or solicitation to buy or sell any security. Although the information contained in this advertisement is believed to be reliable, The Fundamentals Report and its editors make no warranties as to the accuracy of the description of any of the content herein and accept no liability for how readers or listeners  may choose to use it. The Fundamentals Report, including any of our principals, officers, directors, partners, agents, or affiliates are not, nor do we represent ourselves to be, registered investment advisors, brokers, or dealers in securities. Readers and listeners should independently verify all statements made in this advertisement. Product names, logos, brands, and other trademarks featured or referred to within this presentation, The broadcast and on line report are the property of their respective trademark holders. These trademark holders are not affiliated with The Fundamentals Report The radio broadcast and on line report, and the opinions of those quoted within are for informational and advertising purposes only. Speculation in securities carries a high degree of risk, and investors purchasing speculative investments should be capable of absorbing losses of all of their invested capital. There is no assurance that the featured company will receive additional funding or experience any future development necessary for corporate success. Information contained in the broadcast  and on line report contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements regarding the expected continual growth of the market for the company’s products, the company’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance may be forward-looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur. The Fundamentals Report may have been paid a fee by the subject company or may have received compensation from other advertisers shown on the website or aired in the broadcast. The owners of The Fundamentals Report may or may not now or in the future hold stock of the subject company and may or may not intend to sell such stock if held.
Copyright 2019 : The Fundamentals Report
For question, comments or to suggest an article topic please contact :
The Fundamentals Report: Focusing on the Market Sector, The Business Model, The Performance and The Future.
The Sector:  Virtual Reality / Augmented Reality. 
The Fundamentals Report is a nationally aired radio segment providing information and awareness of publicly traded companies with strong fundamentals
There are many investors currently following the resurgence of the Green Rush within the Cannabis sector as legalization continues to expand and global sales estimates expected to reach over 20 billion in 2020. Investing in high growth trends is proven to be one of the best ways to build wealth and although the cannabis sector has proven successful for many investors there is one industry sector that is set to significantly outperform Cannabis with global sales estimates predicted at 75 billion by 2021and a staggering 121 billion within ten years. Nearly triple that of the potential Cannabis market. This same sector is the focus of publicly traded market giants such as Google (NASDAQ: GOOGL), Facebook (NASDAQ:FB), Microsoft (NASDAQ: MSFT) and Sony (NYSE:SNE), and innovative content and technology leader ReelTime VR (OTCMKTS:RLTR) The sector is predicted to bring us the most disruptive technology since the cell phone impacting a wide array of core industries including entertainment, health care, education, retail, military defense, marketing, manufacturing and media, and even the Cannabis sector. This highly disruptive technology which is quickly becoming part of all consumers’ lives and will impact almost every major industry sector is : Virtual Reality / Augmented Reality. Both legal marijuana and Virtual Reality/Augmented Reality are considered high growth sectors, but that is where the similarities end. To date no major drug company such as Pfizer Inc. has invested a single dollar into legal pot. No major Tobacco company such as Phillip Morris (175 Billion) has invested a single dollar in cannabis, and neither has any major alcohol company, in fact the alcohol industry is a leading opponent (of which there are many) to legalized marijuana. Contrast that with VR/AR where nearly every major player in the technology space and most major governments have invested heavily in VR/AR. This includes the top social media company Facebook’s purchase of Oculus for 2 billion. Their firm commitment to focus on Virtual Reality recently launched Facebook 360 which allows all 2.2 billion (and climbing) active Facebook users to experience and share Virtual Reality content. YouTube has also invested deeply in VR now prioritizing VR content over other content to its 1.3 billion active users.  And it does not stop with Social media as Samsung the largest manufacturer of cell phones worldwide has over a million users per month on its Gear VR headsets. Sony PlayStation launched VR games on its Playstation 4 console as did Microsoft on its Xbox One platform. Other standout tech companies invested include Google, IBM, Intel, HP, Foxcon (the world’s largest electronics manufacturer) and other smaller but notable companies such as LG, and HTC have also thrown their hat and money into the ring. In Fact 8 of the top 10 tech companies in the word are invested in VR/AR Whether you've strapped on an Oculus Rift, HTC Vive, PlayStation VR or Google Daydream, or just seen one of those 360 videos on YouTube, or FaceBook chances are you've already sampled virtual reality. From entertainment to educational applications, VR has finally made the transition from science fiction to everyday life, and it's not going anywhere. Per projections from Greenlight Insights, VR is set to reach $7.17 billion in revenue by the end of 2017 and rack up $75 billion globally by 2021. Nearly triple that of the entire Cannabis sector and more than quadrupling it within a decade, and that's just for consumer hardware and content. Sub-industries like location-based VR installations will cross the $1 billion revenue mark by 2021, as well. These factors are expected to contribute towards a double digit compounded annual growth rate (CAGR) during the forecast period 2016 – 2023. Although it is still in the nascent stage, virtual reality is one of the hottest areas of technology growth and innovation, with a potential impact in many sectors. Analyst at top brokerage firms such as Goldman Sachs are aggressively recommending Virtual Reality stocks likening the opportunity to the advent of the television. Piper Jaffray described virtual reality as “the next mega tech theme” going as far as comparing the state of virtual reality today to that of mobile phones 15 years ago. Over the next few years, VR will begin to realize its potential. By next year, there will be an estimated 171 million active VR users generating 121 Billion in sales. Contrast that to the very risky and paltry potential of cannabis which optimistically expected to reach only 20 billion in sales (only 17% of VR/AR) in the same period. This is stifled by a number of insurmountable or at least very challenging facts about Cannabis Companies.
One industry sector that will noticeably outperform the Cannabis Green Rush.
If you are looking to take advantage of a fast moving trend for the purpose of building wealth then the AR/VR industry outperforms the legal marijuana industry on all fronts.
Here are our top 4 picks to look at when considering an investment in the VR/AR space. 1. Alphabet  (GOOGL) Alphabet has both the high and lower ends of VR covered. The company's relatively inexpensive and smartphone-enabled contribution should find widespread consumer acceptance. At $2 a unit, Google Cardboard is literally a cardboard viewer that requires a user to place a smartphone within it and use related apps that can be downloaded from the Google app store. With it owning YouTube which is arguably the most explosive VR content portal GOOGL is committed to be a major player. 2. Facebook (FB) At $600 for the headset and at $1,500 combined with a compatible PC, the product seems a little pricey. However, prices should soon come down as Facebook achieves economies of scale and the technology becomes more mature. And from a content delivery portal Facebook will rival any traditional media conglomerate in its ability to quickly get top content viewed, shared, and discussed worldwide. 3. Sony (SNE) Sony's PlayStation already has a huge and loyal user base. Since launching VR games on the PlayStation 4 it has solidified itself as a major player. The price (nearly 800 plus a PlayStation 4 system) and the requirement to have a PlayStation limit its growth over uninhibited portals such as Facebook, and YouTube. 4. ReelTime VR (OTCPK:RLTR) The only over the counter traded company to make our list ReelTime VR has the largest upside of any VR/AR company due to its relative price to performance and unlimited potential. ReelTime VR has not only focused on technology propelling Virtual Reality but became the first to be able to view high end content on over 2 billion devices worldwide. It has achieved the number one watched content on, the number one children’s non-animated series on Samsung Gear VR, and swept the VR Biz Awards winning both “Best Travel Series” and “Best Live Action” series. It is much less known as the other companies on the list making its entry cost to invest and potential for appreciation unparalleled.
Why Cannabis stocks are causing investors to pull out causing the widespread recent carnage losing investors nearly half of their investments in just the past few weeks alone. Cannabis stocks that recently saw a surge have been hammered lately as investors take a sober look at the serious barriers that exist conducting business, the reality of investing in a federal illegal business, the lack of any major company support, and the opposition of deep pocketed adversarial opponents. Companies such as Potnetwork Holdings (OTCPK:POTN), Amfil Technologies Inc. (OTCPK:AMFE), Sunset Island Group, Inc. (OTCQB:SIGO), Rising India Inc. (OTCPK:RSII), and ON4 Communications (OTCPK:ONCI) all benefited from a recent surge in the past few weeks only to have been plummeted not because of any bad business decisions but simply because of their connection to conducting federally illegal businesses in the Cannabis sector. Although not all Cannabis companies  conduct federally illegal business, the majority are subject to the restrictions and limitations listed below. 1. Cannabis Companies lack access to basic banking services Marijuana businesses face many inherent disadvantages, but one of the biggest is that they have limited or no access to basic banking services, such as a checking account, credit card processing, or lines of credit. Financial institutions ultimately answer to the federal government and providing banking services to the cannabis industry could be construed as money laundering since the drug is still illegal as a schedule 1 drug (classified alongside Heroin and Cocaine) at the federal level. Without basic banking services, pot businesses are forced to deal in cash, which is both a security concern and a growth inhibitor. 2. Cannabis Companies can't take normal business deductions On top of having minimal financial services access, pot businesses are bound by U.S. tax code 280E, which denies them the right to take normal tax deductions since they're selling a federally illegal substance. The end result is that cannabis businesses are paying tax on their gross profit instead of their net profit, thus leaving less money left over to hire, buy new product, innovate, and expand. 3. Nearly all are losing money Another issue that investors would be wise to not overlook is that most marijuana stocks are losing money. A combination of factors that includes a lack of access to banking services, an inability to take tax deductions, and the fact that so few publicly traded companies have any long-term experience in the pot industry, means ongoing losses for many marijuana stocks. 4. The industry is fragmented Another problem for investors is that few big businesses have begun to infiltrate the cannabis industry. there are still far too many small businesses to propel any mass adoption and distribution. While pro-legalization enthusiasts would probably prefer to see small businesses succeed, investors usually need industry consolidation and bigger businesses to have a shot at long-term investing success. Right now, the marijuana industry is far too fragmented to be conducive to long term investment. 5. There's a Congressional Catch-22 Investors are probably not going to get much help from Congress. Lawmakers on Capitol Hill have frequently called for more clinical benefits evidence before they'll even consider legalizing medical cannabis on a national level. But there's a problem. Without loosening restrictions around marijuana's Schedule 1 status, it becomes veritably impossible to run those needed clinical tests. This Congressional Catch-22 probably means many years to come with marijuana remaining as a Schedule 1 substance at the federal level. 6. Expansion is more limited than advertised Investors might also be wary of cannabis' supposed expansion opportunities. Right now there are 22 states that haven't legalized medical marijuana and 42 that haven't legalized recreational weed.  However, 24 of the 50 states in the U.S. don't have initiative and referendum (I&R) laws, meaning only the legislatures of these two dozen states can pass laws pertaining to marijuana. 7. Rescheduling marijuana from a schedule 1 drug may be even worse Finally, even if Congress or the DEA have a change of heart and reschedule marijuana to Schedule 2, it doesn't necessarily make things easier for pot businesses or investors. Though it would allow the drug to be prescribed medically in all 50 states, it would also put the Food and Drug Administration firmly in control. The FDA could control the marketing and packaging of cannabis products, would almost certainly tightly oversee the manufacturing and processing of medical cannabis, and may make the industry run costly and lengthy clinical tests to demonstrate the effectiveness of marijuana in treating certain ailments. This last component is exceptionally costly and could drive some pot businesses to the sidelines. Though legal pot sales are soaring, the deck is clearly stacked against marijuana stocks.